Red cell distribution width-to-platelet ratio (RPR) as a predictor of prolonged stay at hospital for COVID-19 inpatients Authors: Martha Fors, Santiago J Ballaz Published: 2024 ABSTRACT AbstractAims/BackgroundWe looked at novel hematological composites like the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, red cell distribution width-to-lymphocyte ratio, red cell distribution width-to-platelet ratio, leukocyte-to-C reactive protein ratio, and lymphocyte-to-C reactive protein ratio as explanatory variables for COVID-19 patients´ hospital length of stay (LoS).MethodsThe association of hematological indices with LoS was analyzed on 2930 COVID-19 patients using the univariate and multivariable Cox proportional hazards regression models with enter method. The Kaplan-Meier survival estimates were applied to LoS.ResultsThe survivors´ mean LoS was 7.8 ± 24.0 days, but the deaths´ mean LoS was 38.6 ± 41.9 days (W = 31338, p < 0.01). Every hematological scores representative of the inflammatory status was significantly correlated in the univariate analysis with a prolonged LoS (p < 0.001). In the multivariate analysis, it was discovered that just the monocyte-to-lymphocyte and lymphocyte-to-C reactive protein ratios had not achieved statistical significance. However, most systemic inflammation measures showed hazards ratios close to one. One exemption was the red cell distribution width-to-platelet ratio (RPR) index, which can increase the probability of a longer hospital stay by up to ten times (HR(IC95%) = 0.092(0.03-0.29); p < 0.001).ConclusionThe most effective biomarker to identify COVID-19 patients at high risk for extended hospital stay was RPR.Highlights Introduction Determining hospital Length of Stay (LoS) is vital for resource management, especially for future COVID-19 outbreaks.Previous studies have primarily focused on sociodemographic and clinical attributes, along with resource availability, but have not accounted for other factors like routine laboratory tests, which can significantly impact LoS predictions.This study examines novel hematology scores as predictors of LoS, emphasizing their importance in resource-limited settings like Ecuador. Methods This retrospective cohort study analyzed 2,930 COVID-19 patients admitted to Hospital IESS Quito Sur in Ecuador focusing on confirmed cases with complete blood count (CBC) values to assess LoS.The study explored various hematological ratios, such as the neutrophil-to-lymphocyte ratio (NLR) and red cell distribution width-to-lymphocyte ratio (RLR), as potential predictors of LoS and in-hospital outcomes for COVID-19 patients, using a combination of univariate and multivariable Cox proportional hazards regression models.Kaplan-Meier survival estimates and log-rank tests were used to analyze survival and discharge probabilities over time, highlighting sex-dependent effects and the significant association between selected hematological indices and patient outcomes. Results The mean LoS for survivors was significantly shorter compared to those who died (p < 0.001), indicating that longer hospitalization was associated with higher mortality risk.Women had a shorter average LoS (with lower mortality risk (p < 0.001), suggesting an asymmetrical hospitalization pattern based on sex.While most hematological markers had minimal clinical relevance for LoS, the red cell distribution width-to-platelet ratio (RPR) stood out, increasing the likelihood of a longer hospital stay by up to tenfold, making it a critical factor in predicting prolonged hospitalization. Discussion Men had longer hospital stays and higher mortality rates than women, likely due to differing inflammatory responses, though hyperinflammation markers like NLR, PLR, and Leu-CPR had minimal clinical impact.RPR had the strongest link to longer hospital stays, indicating a higher risk of extended hospitalization in severe COVID-19 cases.Elevated RPR is tied to oxidative stress and coagulation issues, suggesting early identification could help reduce prolonged stays and complications. Conclusion Research generally points to clinical complications from COVID-19 as the main factor behind prolonged hospitalizations, underlining the importance of early identification and management of these issues.Keywords: COVID-19, C-reactive protein, erythrocyte indices, length of stay, leukocyte count, lymphocyte count, platelet count, survival analysis Introduction COVID-19 disease is a highly contagious disease caused by the coronavirus SARS-CoV-2 that affects lungs, airways and other organs. December 2019 saw the identification of the first case in Wuhan (china). Since then, a number of strains that spread among people have been found, posing a significant risk to public health and economy [1]. Determining hospital length of stay (LoS) in hospitals is critical information for improving hospital resource allocation and emergency preparation in the light of the potential for future COVID-19 outbreaks. The sociodemographic (age, ethnicity, sex, occupation, residence, healthcare insurance), clinical attributes (comorbidities, COVID-19 clinical stage) and availability of resources at initial evaluation have been the only parameters considered in the investigation of factors impacting LoS [2]. Factors unrelated with infection pathology lead reported LoS to differ dramatically between geographic regions rather than the severity of the illness. Researchers have seen that routine laboratory tests can accurately predict the clinical consequences of COVID-19 infection. This study aimed to assess the appropriate application of novel combined hematology scores in the domain of systemic inflammation [3] as explanatory factors for COVID-19 patients´ duration of hospital stay (namely LoS). The rationale behind it was that some these factors could forecast the severity of COVID-19 and the rate of in-hospital mortality [4, 5], which could be related to the number of days of hospitalization. The relationship of explanatory variables to prolonged hospitalization like comorbidities, insufficient respiratory therapy, age, and, sex is crucially important in low-income countries like Ecuador, which acted as the COVID-19 pandemic´s zero zone in South America. In this study we suggest that the discovery of targeted inflammatory measures that assess functional status and avert complications could also reduce LoS. Only a few indicators such as low serum albumin, elevated LDH levels [6], total leukocyte count, D-dimer, and CPR [7], have been given any thought as LosS predictors. This study went one step further and evaluated combinations of routine hematology tests only for their ability to predict COVD-19 mortality [4]. Methods Selection of COVID-19 patients This retrospective cohort study analyzed 2,930 COVID-19 patients admitted from March 13 to June 17, 2020, at Hospital IESS Quito Sur in Quito (Ecuador). Inclusion criteria required patients to have confirmed COVID-19 diagnosis through RT-PCR testing and complete blood count (CBC) values within 48 hours of admission. Exclusion criteria included patients under 18 years of age, those with missing hematological data, or those discharged within 24. All the patients had a positive RT-qPCR test for Sars-CoV-2 (CDC 2019-Novel Coronavirus Real-Time RT-qPCR Diagnostic Panel upper and lower respiratory specimens) and a pneumonia severity index (PSI) > 3, as well as an arterial blood gasometry exam during the triage evaluation. Blood samples for routine laboratory tests were drawn upon admission after a 40-min interval of average. A complete blood count was obtained by rapidly running the blood samples in a Sysmex XN-550™ Hematology Analyzer (Sysmex America Inc., Japan). Hospital length of stay (LoS) defined the total of days that patients spent in the hospital from admission to either home discharge or death. COVID-19 patient selection Patient demographic information (age, gender), clinical characteristics (comorbidities such as diabetes, hypertension, and cardiovascular disease), and hospital outcomes (length of stay [LoS], ICU admission, mechanical ventilation) were extracted from electronic medical records. Hematological parameters were calculated from CBC data obtained at admission, and CRP levels were included as a marker of systemic inflammation. Statistics Statistical analysis of the data was performed using the SPSS software (version 24.0) for Windows (IBM, Armonk, NY, USA). Hospital length of stay (LoS) defined the total of days that patients spent in the hospital from admission to either home discharge or death. The initial feature selection encompassed an exploratory analysis of preselected hematological scores (the exploratory outcome measures) relevant to COVID-19 severity and in-hospital mortality [4, 5] able to reach the better statistical significance levels, when combined in proportional hazards regressions. The following hematological indices (the primary outcome measures) were then selected: neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), red cell distribution width to-lymphocyte ratio (RLR), red cell distribution width-to-platelet ratio (RPR), leukocyte-to-C reactive protein ratio (Leu-CPR), and lymphocyte-to-C reactive protein ratio (Ly-CPR). The association of risk factors with LoS was assessed in both the univariate and multivariable Cox proportional hazards regression models with enter method. In the case of the analysis of the sample nature, the Mann and Whitney test was conducted to compare LoS means between Survivor and non-Survivor groups of patients. The same statistical procedure was applied to analyze sex-dependent effects on survival. The Kaplan-Meier survival estimates was used to estimate the probability of hospital discharge and the log-rank test were used to compare men and women in terms of survival. Cumulative functions of hospital stay and death probability during hospitalization (the secondary outcome measures) time helped compare sex-dependent differences in survival and hazard functions from the survival dataset. Data were presented as mean ± SD. Alpha value was set at 0.05 for statistical significance. Ethics Written informed consent and evaluation by a Human Research Ethics Committee was waived, because the study is observational and retrospective in nature (non-experimental research with secondary data, anonymized patients, and descriptive design). The permission to download the data from the digital clinical records system was granted by the CEO of the IESS Hospital Quito Sur, who attested to the protection of patient confidentiality in accordance with the policies established by the Ecuadorian government during the COVID-19 pandemic and the Declaration of Helsinki. We followed the STROBE guidelines. Results Nature, distribution, and survival analysis of the sample LoS mean among those who survived was 7.8 ± 24.0 days, a shorter stay compared to those who died that was 38.6 ± 41.9 days (W = 31338; p < 0.001). The averaged LoS for women and men were 6.4 ± 21.0 and 10.5 ± 27.5 days respectively (W = 981634; p < 0.001). Hospitalization time showed an asymmetrical pattern by sex, demonstrating that women had a lower average risk for mortality and shorter LoS compared to men (χ2 = 31.52; p < 0.001) (Figure 1). Cumulative functions during hospitalization time. Survival (left) and cumulative risk (right) functions. LoS associated risk factors All the systemic inflammation-inspired hematological markers were substantially associated in the univariate analysis with a longer LoS (Table 1). For example, the probability of a longer hospital stay doubles with the MLR index (HR(IC95%) = 0.460(0.387-0.547); p < 0.001), but it increases tenfold with PLR (HR(IC95%) = 0.460(0.387-0.547); p < 0.001). The multivariable analysis revealed that only MLR and Ly-CPR missed statistical significance. However, the majority of the systemic inflammatory indices had hazard ratios that were nearly 1, which turned out irrelevant from a clinical standpoint. The RPR index was an exception, as it can rise the likelihood of a lengthier hospital stay by up to ten times (HR(IC95%) = 0.092(0.03-0.29); p < 0.001). Table 1.Univariate and multivariate Cox proportional hazards regression analysis of novel hematological factors associated with LoS.HematologicalUnadjustedAdjustedindicesHR(IC95%)p value*HR(IC95%)p value* NLR 0.95(0.94-0.96)<0.0011.057(1.01-1.09)0.004 PLR 1.00(1.00-1.00)<0.0010.98(0.97-0.99)0.023 MLR 0.46(0.38-0.54)<0.0010.88(0.64-1.22)0.470 RLR 0.98(0.98-0.99)<0.0010.98(0.98-0.99)<0.001 RPR 0.09(0.05-0.18)<0.0010.09(0.03-0.29)<0.001 Leu-CPR 1.01(1.01-1.02)<0.0011.01(1.00-1.02)0.047 Ly-CPR 1.05(1.03-1.06)<0.0011.00(0.97-1.03)0.769*Cox Proportional Hazards Regression. Univariate and multivariate Cox proportional hazards regression analysis of novel hematological factors associated with LoS. *Cox Proportional Hazards Regression. Discussion Because men´s inflammatory responses varied from women´s [8], men had longer LoS, and greater fatality rates than women [9] The length of hospital stay was statistically associated with indicators such as NLR, PLR and Leu-CPR [5, 10] that suggest a hyper-inflammation condition in cases of severe COVID-19. Nevertheless, the results were clinically insignificant and enable to robustly change LoS. It is interesting to note that the most robust statistically significant association with LoS was seen in a RDW-related index like RPR [4]. The higher the RPR values, the lengthier hospital stay. Sex and RPR were found to be as the most clinically significant risk factors in this study for a prolonged hospital stay. The RDW is one of the most reliable prognostic indicators of COVID-19 hyperinflammation, severity, and mortality in COVID-19 patients [11–14]. Platelets have a significant influence in inflammation [15] and severity in COVID-19 disease [16], thus the platelet count would be a good way to normalize the RDW. Clotting plays a role in cardiovascular problems and stroke [17], both of which are frequent in COVID-19 patients [18, 19]. Although in-hospital mortality in critically ill patients with myocardial infarct conditions [20] and acute ischemic stroke [21, 22] can be predicted by an elevated RPR score, COVID-19 mortality does not follow this pattern [4]. The current research indicates that a greater RPR would be a stronger predictor of a prolonged COVID-19 recovery in the hospital. The underlying causes are still unclear. Given that RDW is a measure of red blood cell size variation as determined by a hematology analyzer, it may serve as a marker of oxidative for stress and tissue hypoxia, both of which are prevalent in severe COVID-19 cases [23]. Variations in platelet counts are crucial in hemostatic and vascular diseases associated to COVID-19 [24], whereas persistent inflammations can alter RDW [25]. Accordingly, in cases with severe COVID-19, a rise in RDW in conjunction with a decrease in platelet counts may indicate the interaction of endothelial dysfunction, coagulation anomalies, and inflammation [26]. Because an elevated RPR score is a strong indicator of death in sepsis patients [27], it is likely that complications from SARS-CoV-2 infection are the reason of this raised score and the lengthier hospitalization. Potential limitations include the studýs retrospective character, which makes it difficult to infer causality between hematological indices and extended LoS. It is also possible that the results of this single-center study might not be generalized to other healthcare settings. Hematological data collected at admission, might not accurately reflect how the illness progressed. Residual confounding variables like illness severity and treatments cannot be ruled out. Finally, due to the rapid evolution of COVID-19 variants and treatments, the applicability of these findings in the future may be limited. Nevertheless, the sizable patient population in both cohorts improves the finding´s generalizability This study provided a comprehensive evaluation of inflammatory biomarkers, including the novel RPR index, and their potential value in forecasting LoS. Furthermore, the application of both univariate and multivariable Cox proportional hazards regression models along with the Kaplan-Meier survival curves enhanced the interpretability of the results. Further prospective studies are needed to confirm these associations and explore the potential for dynamic monitoring of these biomarkers. Conclusions Researchers have mostly concluded that the primary factor causing extended hospital stays is clinical complications brought on by COVID-19 infection. According to our findings, novel hematological scores such as RPR, that are indicative of the state of systemic inflammation may be a predictor of these complications before they arise. Acknowledgments We express our gratitude to the medical staff at the IESS Hospital Quito Sur in Quito (Ecuador), who worked with us to manage the database under the direction of the hospital´s CEO, Dr. Francisco Mora. We would especially like to thank Francisco Mora and the medical personnel of the IESS Hospital Quito Sur (HQSUR). Author contributions Both authors made equal contributtion to the present studýs inception, development, and writing. Disclosure statement The authors have no financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. Data availability statement The datasets generated analyzed during the current study are available from the corresponding author on reasonable request. References Papers of special note have been highlighted as either of interest (*) or of considerable interest (**) to readers Associated Data Data Availability Statement The datasets generated analyzed during the current study are available from the corresponding author on reasonable request.